SCNX (Scienture Holdings) EPS without NRI: $-1.26 (TTM As of Mar. 2026)


SCNX Scienture Holdings Inc SCNX
47 GF Score
Price $0.35
GF Value $0.35
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Scienture Holdings EPS without NRI?

Scienture Holdings SCNX 47 EPS without NRI is $-1.26 as of Mar. 2026. GuruFocus rates SCNX with a GF Score™ of 47/100 and a GF Value™ of $0.35 (Fairly Valued). The stock has 6 warning signs investors should review. Among 511 Healthcare Providers & Services companies, Scienture Holdings ranks better than 71.62% on this metric.

Scienture Holdings's earnings per share without non-recurring items for the three months ended in Mar. 2026 was $-0.08. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was $-1.26.

During the past 3 years, the average earnings per share (NRI) Growth Rate was 28.50% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 14.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Scienture Holdings's EPS without NRI or its related term are showing as below:

SCNX' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -40.7   Med: 11.9   Max: 38.9
Current: 28.5

During the past 13 years, Scienture Holdings's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 38.90% per year. The lowest was -40.70% per year. And the median was 11.90% per year.

SCNX's 3-Year EPS without NRI Growth Rate is ranked better than
71.62% of 511 companies
in the Healthcare Providers & Services industry
Industry Median: 11.5 vs SCNX: 28.50

Scienture Holdings's EPS (Diluted) for the three months ended in Mar. 2026 was $-0.08. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $-2.51.

Scienture Holdings's EPS (Basic) for the three months ended in Mar. 2026 was $-0.08. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $-2.51.


Scienture Holdings  (NAS:SCNX) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Scienture Holdings EPS without NRI Related Terms


Scienture Holdings EPS without NRI Historical Data

* Premium members only.

The historical data trend for Scienture Holdings's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scienture Holdings EPS without NRI Chart

Scienture Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.80 -3.40 -9.86 -4.65 -1.24

Scienture Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.46 -0.41 -0.32 -0.44 -0.08

SCNX vs WGRX, HEWA, BLMH: EPS without NRI Comparison

For the Pharmaceutical Retailers subindustry, Scienture Holdings's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scienture Holdings PE Ratio without NRI vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Scienture Holdings's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Scienture Holdings's PE Ratio without NRI falls into.


SCNX
47GF Score
Scienture Holdings Inc SCNX
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scienture Holdings EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $-1.26 mean?
Scienture Holdings (SCNX) has a EPS without NRI of $-1.26 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Scienture Holdings and its competitors. According to the industry distribution chart, Scienture Holdings ranks #145 out of 511 companies in the Healthcare Providers & Services industry, placing it in the top 28.4%.
Is Scienture Holdings' EPS without NRI too high?
Scienture Holdings' current EPS without NRI is $-1.26. Based on the distribution chart, Scienture Holdings ranks #145 out of 511 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Scienture Holdings has a GF Score™ of 47/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Scienture Holdings' EPS without NRI compare to WGRX and HEWA?
According to the Healthcare Providers & Services industry distribution chart, Scienture Holdings ranks #145 out of 511 companies for EPS without NRI. This puts Scienture Holdings in the upper half of its industry. The industry median EPS without NRI is 11.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Healthcare Providers & Services company?
The median EPS without NRI among Healthcare Providers & Services companies is 11.50, based on 511 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Scienture Holdings and its competitors. For the Healthcare Providers & Services industry, the median EPS without NRI is 11.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Scienture Holdings's current EPS without NRI is $-1.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scienture Holdings stock overvalued right now?
Based on GuruFocus' analysis, Scienture Holdings (SCNX) is currently considered Fairly Valued. The stock's GF Value™ is $0.35, compared to a current price of $0.35 — trading 1.3% below its estimated fair value. The current EPS without NRI is $-1.26. Scienture Holdings' overall GF Score™ is 47/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Scienture Holdings (SCNX), the current EPS without NRI is $-1.26 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Scienture Holdings (SCNX) Overvalued in 2026?

Based on GuruFocus' analysis, Scienture Holdings stock appears to be undervalued. The current stock price of $0.35 is trading 1.3% below its estimated GF Value™ of $0.35. GuruFocus considers Scienture Holdings to be Fairly Valued.

Key valuation signals for SCNX:

  • EPS without NRI: $-1.26
  • GF Value™: $0.35 vs. price of $0.35 (1.3% below fair value)
  • GF Score™: 47/100 with 6 warning signs

No single metric tells the full story. See the SCNX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Scienture Holdings Business Description

Other Exchanges 4E4:Germany
Address 20 Austin Boulevard, Commack, NY, USA, 11725
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.
47GF Score

Get the complete analysis for SCNX

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.35
Price
$0.35
GF Value